See up to 3 months of RDGL. The 7-day demo opens the 1M and 3M ranges and puts RDGL on your watchlist.
Start 7-day demoLatest RDGL insider trades
Michael K. Korenko - OfficerOpen-market purchase$100K- Brad Allan Weeks - OfficerOpen-market purchase$1K
About VIVOS INC (RDGL)
The SEC lists VIVOS INC under CIK 0001449349, in surgical and medical instruments and apparatus. We track it alongside the rest of the Health Care sector.
RDGL Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 6 | 517,550 | $116K |
| Grant or award | 1 | 635,302 | |
| Derivative transaction | 1 | 385,302 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
RDGL insider transactions (Form 4)
1913 Form 4 filings on record, the earliest from Oct 28, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Carlton M. Cadwell - Director | Derivative | Series C Convertible Preferred | 385,302 | - footnote F1 | - | |
| Carlton M. Cadwell - Director | Grant or award | Series D Convertible Preferred | 635,302 | - footnote F1 | - | |
| ||||||
| Michael K. Korenko - Officer | Open-market purchase | Common Stock | 200,000 | $0.50 | $100K | |
| Brad Allan Weeks - Officer | Open-market purchase | Common Stock | 25,550 | $0.05 footnote F1 | $1K | |
| ||||||
| Brad Allan Weeks - Officer | Open-market purchase | Common Stock | 50,000 | $0.05 | $3K | |
| Michael K. Korenko - Officer | Open-market purchase | Common Stock | 150,000 | $0.05 | $8K | |
| Brad Allan Weeks - Officer | Open-market purchase | Common Stock | 60,000 | $0.05 | $3K | |
| Brad Allan Weeks - Officer | Open-market purchase | Common Stock | 32,000 | $0.05 | $2K | |
| Brad Allan Weeks - Officer | Grant or award | Common Stock | 100,111 | $0.00 | - | |
| Brad Allan Weeks - Officer | Grant or award | Common Stock | 147,159 | $0.00 | - | |
| Brad Allan Weeks - Officer | Open-market purchase | Common Stock | 48,000 | $0.08 | $4K | |
| Brad Allan Weeks - Officer | Open-market purchase | Common Stock | 12,000 | $0.08 | $960 | |
| Michael K. Korenko - Officer | Open-market purchase | Common Stock | 200,000 | $0.06 | $11K | |
| Brad Allan Weeks - Officer | Open-market purchase | Common Stock | 48,000 | $0.08 | $4K | |
| Brad Allan Weeks - Officer | Open-market purchase | Common Stock | 12,000 | $0.08 | $960 | |
| Michael K. Korenko - Officer | Open-market purchase | Common Stock | 150,000 | $0.06 | $9K | |
| Michael K. Korenko - Officer | Open-market purchase | Common Stock | 100,000 | $0.06 | $6K | |
| Michael K. Korenko - Officer | Open-market purchase | Common Stock | 100,000 | $0.08 | $8K | |
| Michael K. Korenko - Officer | Open-market purchase | Common Stock | 50,000 | $0.14 | $7K | |
RDGL insider trading FAQ
What is the latest insider trade for RDGL?
VIVOS INC (RDGL) had 6 insider filings in the last 90 days, with the most recent on 2026-10-08. The full record for RDGL runs to 13 Form 4 filings, the earliest from 2024-10-28. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying RDGL stock?
6 insider purchases of RDGL were filed in the last 90 days, totaling $116K.
How many insiders are selling RDGL stock?
No insider sales of RDGL were filed in the last 90 days.
Where can I see RDGL SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects RDGL Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Carlton M. Cadwell view on EDGAR
- - Michael K. Korenko view on EDGAR
- - Brad Allan Weeks view on EDGAR
- - Brad Allan Weeks view on EDGAR
- - Michael K. Korenko view on EDGAR
- - Brad Allan Weeks view on EDGAR
- - Brad Allan Weeks view on EDGAR
- - Michael K. Korenko view on EDGAR
- - Brad Allan Weeks view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where RDGL's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow RDGL with a 7-day demo
- RDGL on your watchlist
- Every RDGL Form 4 filing on record
- Up to 3 months of RDGL price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
